Alphabiome

The Biological Intelligence Layer for AI

Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M SeedMay 2025
Rounds
1

About

Alphabiome is the AI layer for drug development. We read the raw bacterial, viral, and host DNA that has no reference map, computing over signal others cannot, to reveal which therapies work, in which patients and why. The biological intelligence layer predicts treatment response: which patients are likely to respond, which are not, and why. This turns years of translational research into days of computation and enables trials to run with fewer, better-selected patients, lowering cost and risk across development.

Summary

Alphabiome is an Artificial Intelligence company. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in May 2025. Investors include AIX Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedMay 2025
$8.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alphabiome on Indexed.vc
<a href="https://indexed.vc/companies/alphabiome"><img src="https://indexed.vc/api/badge/company/alphabiome" alt="Alphabiome on Indexed.vc" width="260" height="76" /></a>